<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.malariajournal.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Malaria Journal - Latest Articles</title>
        <link>http://www.malariajournal.com</link>
        <description>The latest research articles published by Malaria Journal</description>
        <dc:date>2012-02-03T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/11/1/33" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/11/1/32" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/11/1/31" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/11/1/30" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/11/1/29" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/11/1/28" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/11/1/27" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/11/1/26" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/11/1/25" />
                                <rdf:li rdf:resource="http://www.malariajournal.com/content/11/1/24" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.malariajournal.com/content/11/1/33">
        <title>Cytoadherence and virulence - the case of Plasmodium knowlesi malaria</title>
        <description>Background:
Cytoadherence of infected red blood cells to brain endothelium is causally implicated in malarial coma, one of the severe manifestations of falciparum malaria. Cytoadherence is mediated by specific binding of variant parasite antigens, expressed on the surface of infected erythrocytes, to endothelial receptors including, ICAM-1, VCAM and CD36. In fatal cases of severe falciparum malaria with coma, blood vessels in the brain are characteristically congested with infected erythrocytes. Brain sections from a fatal case of knowlesi malaria, but without coma, were similarly congested with infected erythrocytes. The objective of this study was to determine the binding phenotype of Plasmodium knowlesi infected human erythrocytes to recombinant human ICAM-1, VCAM and CD36.
Methods:
Five patients with PCR-confirmed P. knowlesi malaria were recruited into the study with consent between April and August 2010. Pre-treatment venous blood was washed and cultured ex vivo to increase the proportion of schizont-infected erythrocytes. Cultured blood was seeded into Petri dishes with triplicate areas coated with ICAM-1, VCAM and CD36. Following incubation at 37degreesC for one hour the dishes were washed and the number of infected erythrocytes bound/mm2 to PBS control areas and to recombinant human ICAM-1 VCAM and CD36 coated areas were recorded. Each assay was performed in duplicate. Assay performance was monitored with the Plasmodium falciparum clone HB3.
Results:
Blood samples were cultured ex vivo for up to 14.5 h (mean 11.3 +/- 1.9 h) to increase the relative proportion of mature trophozoite and schizont-infected red blood cells to at least 50% (mean 65.8 +/- 17.51%). Three (60%) isolates bound significantly to ICAM-1 and VCAM, one (20%) isolate bound to VCAM and none of the five bound significantly to CD36.
Conclusions:
Plasmodium knowlesi infected erythrocytes from human subjects bind in a specific but variable manner to the inducible endothelial receptors ICAM-1 and VCAM. Binding to the constitutively-expressed endothelial receptor CD36 was not detected. Further work will be required to define the pathological consequences of these interactions.</description>
        <link>http://www.malariajournal.com/content/11/1/33</link>
                <dc:creator>Farrah Fatih</dc:creator>
                <dc:creator>Angela Siner</dc:creator>
                <dc:creator>Atique Ahmed</dc:creator>
                <dc:creator>Lu Chan Woon</dc:creator>
                <dc:creator>Alister Craig</dc:creator>
                <dc:creator>Balbir Singh</dc:creator>
                <dc:creator>Sanjeev Krishna</dc:creator>
                <dc:creator>Janet Cox-Singh</dc:creator>
                <dc:source>Malaria Journal 2012, null:33</dc:source>
        <dc:date>2012-02-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-11-33</dc:identifier>
                                    <dc:description>Another twist in the tale of cytoadherence ? Is in vitro cytoadherence really a marker of virulence, even in case of parasites, such as P. knowlesi or P. vivax, which are not normally sequestered ?</dc:description>
                <prism:require>/content/figures/1475-2875-11-33-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>33</prism:startingPage>
        <prism:publicationDate>2012-02-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/11/1/32">
        <title>Can universal insecticide-treated net campaigns achieve equity in coverage and use? The case of northern Nigeria</title>
        <description>Background:
Insecticide-treated nets (ITNs) are effective tools for malaria prevention and can significantly reduce severe disease and mortality due to malaria, especially among children under five in endemic areas. However, ITN coverage and use remain low and inequitable among different socio-economic groups in sub-Saharan Africa, particularly in Nigeria. Several strategies have been proposed to increase coverage and use and reduce inequity in Nigeria, including free distribution campaigns recently conducted by the Nigerian federal government. Using data from the first post-campaign survey, the authors investigated the effect of the mass free distribution campaigns in achieving equity in household ownership and use of ITNs.
Methods:
A post-campaign survey was undertaken in November 2009 in northern Nigeria to assess the effect of the campaigns in addressing equity across different socio-economic groups. The survey included 987 households randomly selected from 60 clusters in Kano state. Using logistic regression and the Lorenz concentration curve and index, the authors assessed equity in ITN coverage and use.
Results:
ITN ownership coverage increased from 10% before the campaigns to 70%-a more than fivefold increase. The campaigns reduced the ownership coverage gap by 75%, effectively reaching parity among wealth quintiles (Concentration index 0.02, 95% CI (0.02; 0.05) versus 0.21 95%CI (0.08; 0.34) before the campaigns). ITN use (individuals reporting having slept under an ITN the night before the survey visit) among individuals from households owning at least one ITN, was 53.1% with no statistically significant difference between the lowest, second, third and fourth wealth quintiles and the highest wealth quintile (lowest: odds ratio (OR) 0.87, 95% confidence interval (CI) (0.67;1.13); second: OR 0.85, 95% CI (0.66;1.24); third: OR 1.10 95% CI (0.86;1.4) and fourth OR 0.91 95% CI (0.72;1.15).
Conclusion:
The campaign had a significant impact by increasing ITN coverage and reducing inequity in ownership and use. Free ITN distribution campaigns should be sustained to increase equitable coverage. These campaigns should be supplemented with other ITN distribution strategies to cover newborns and replace aging nets.</description>
        <link>http://www.malariajournal.com/content/11/1/32</link>
                <dc:creator>Yazoume Ye</dc:creator>
                <dc:creator>Elizabeth Patton</dc:creator>
                <dc:creator>Albert Kilian</dc:creator>
                <dc:creator>Samantha Dovey</dc:creator>
                <dc:creator>Erin Eckert</dc:creator>
                <dc:source>Malaria Journal 2012, null:32</dc:source>
        <dc:date>2012-02-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-11-32</dc:identifier>
                                    <dc:description>Using data from a post-campaign survey, the authors investigated the effect of the mass distribution campaigns in achieving equity in household ownership and use ITNs</dc:description>
                <prism:require>/content/figures/1475-2875-11-32-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>32</prism:startingPage>
        <prism:publicationDate>2012-02-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/11/1/31">
        <title>Attractive toxic sugar bait (ATSB) methods decimate populations of Anopheles malaria vectors in arid environments regardless of the local availability of favoured sugar-source blossoms</title>
        <description>Background:
Attractive toxic sugar bait (ATSB) methods are a new and promising &quot;attract and kill&quot; strategy for mosquito control. Sugar-feeding female and male mosquitoes attracted to ATSB solutions, either sprayed on plants or in bait stations, ingest an incorporated low-risk toxin such as boric acid and are killed. This field study in the arid malaria-free oasis environment of Israel compares how the availability of a primary natural sugar source for Anopheles sergentii mosquitoes: flowering Acacia raddiana trees, affects the efficacy of ATSB methods for mosquito control.
Methods:
A 47-day field trial was conducted to compare impacts of a single application of ATSB treatment on mosquito densities and age structure in isolated uninhabited sugar-rich and sugar-poor oases relative to an untreated sugar-rich oasis that served as a control.
Results:
ATSB spraying on patches of non-flowering vegetation around freshwater springs reduced densities of female An. sergentii by 95.2% in the sugar-rich oasis and 98.6% in the sugar-poor oasis; males in both oases were practically eliminated. It reduced daily survival rates of female An. sergentii from 0.77 to 0.35 in the sugar-poor oasis and from 0.85 to 0.51 in the sugar-rich oasis. ATSB treatment reduced the proportion of older more epidemiologically dangerous mosquitoes (three or more gonotrophic cycles) by 100% and 96.7%, respectively, in the sugar-poor and sugar-rich oases. Overall, malaria vectorial capacity was reduced from 11.2 to 0.0 in the sugar-poor oasis and from 79.0 to 0.03 in the sugar-rich oasis. Reduction in vector capacity to negligible levels days after ATSB application in the sugar-poor oasis, but not until after 2 weeks in the sugar-rich oasis, show that natural sugar sources compete with the applied ATSB solutions.
Conclusion:
While readily available natural sugar sources delay ATSB impact, they do not affect overall outcomes because the high frequency of sugar feeding by mosquitoes has an accumulating effect on the probability they will be attracted to and killed by ATSB methods. Operationally, ATSB methods for malaria vector control are highly effective in arid environments regardless of competitive, highly attractive natural sugar sources in their outdoor environment.</description>
        <link>http://www.malariajournal.com/content/11/1/31</link>
                <dc:creator>John Beier</dc:creator>
                <dc:creator>Gunter Muller</dc:creator>
                <dc:creator>Weidong Gu</dc:creator>
                <dc:creator>Kristopher Arheart</dc:creator>
                <dc:creator>Yosef Schlein</dc:creator>
                <dc:source>Malaria Journal 2012, null:31</dc:source>
        <dc:date>2012-02-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-11-31</dc:identifier>
                                    <dc:description>This field study in the arid malaria-free oasis environment of Israel compares how the availability of a primary natural sugar source for mosquitoes - flowering Acacia trees - affects the efficacy of ATSB methods for mosquito control.</dc:description>
                <prism:require>/content/figures/1475-2875-11-31-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>31</prism:startingPage>
        <prism:publicationDate>2012-02-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/11/1/30">
        <title>Apoptosis of the fibrocytes type 1 in the spiral ligament and blood labyrinth barrier disturbance cause hearing impairment in murine cerebral malaria</title>
        <description>Background:
Experimental murine malaria has been shown to result in significant hearing impairment. Microscopic evaluation of the temporal bones of these animals has revealed regular morphology of the cochlea duct. Furthermore, the known vascular pathologic changes being associated with malaria could not be found. Immunohistochemistry for ICAM1 showed a strong marking in the stria vascularis, indicating a disturbance of the endocochlear potential. The aim of this study was to evaluate the role of apoptosis and the disturbance of the blood labyrinth barrier in the murine malaria associated hearing impairment.
Methods:
The temporal bones of seven mice with cerebral malaria--four with hearing impairment, three without hearing impairment--were evaluated with immunohistochemistry for cleaved caspase 3 to detect apoptosis and connexin 26, a gap junction protein being a cornerstone in the endocochlear potassium recirculation. Furthermore five animals with cerebral malaria were treated with Evans blue prior to sacrification to detect disturbances of the blood labyrinth barrier.
Results:
Cleaved caspase 3 could clearly be detected by immunohistochemistry in the fibrocytes of the spiral ligament, more intensively in animals with hearing impairment, less intensively in those without. Apoptosis signal was equally distributed in the spiral ligament as was the connexin 26 gap junction protein. The Evans blue testing revealed a strong signal in the malaria animals and no signal in the healthy control animals.
Conclusion:
Malfunction of the fibrocytes type 1 in the spiral ligament and disruption of the blood labyrinth barrier, resulting in a breakdown of the endocochlear potential, are major causes for hearing impairment in murine cerebral malaria.</description>
        <link>http://www.malariajournal.com/content/11/1/30</link>
                <dc:creator>Joachim Schmutzhard</dc:creator>
                <dc:creator>Christian Kositz</dc:creator>
                <dc:creator>Rudolf Glueckert</dc:creator>
                <dc:creator>Erich Schmutzhard</dc:creator>
                <dc:creator>Annelies Schrott-Fischer</dc:creator>
                <dc:creator>Peter Lackner</dc:creator>
                <dc:source>Malaria Journal 2012, null:30</dc:source>
        <dc:date>2012-02-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-11-30</dc:identifier>
                                    <dc:description>The paper describes histopathological changes induced by a murine malaria infection and relates this with hearing loss. It uses a well-stablished experimental model and addresses a major issue for malaria patients.</dc:description>
                <prism:require>/content/figures/1475-2875-11-30-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>30</prism:startingPage>
        <prism:publicationDate>2012-02-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/11/1/29">
        <title>The complexities of malaria disease manifestations with a focus on asymptomatic malaria</title>
        <description>Malaria is a serious parasitic disease in the developing world, causing high morbidity and mortality. The pathogenesis of malaria is complex, and the clinical presentation of disease ranges from severe and complicated, to mild and uncomplicated, to asymptomatic malaria. Despite a wealth of studies on the clinical severity of disease, asymptomatic malaria infections are still poorly understood. Asymptomatic malaria remains a challenge for malaria control programs as it significantly influences transmission dynamics. A thorough understanding of the interaction between hosts and parasites in the development of different clinical outcomes is required. In this review, the problems and obstacles to the study and control of asymptomatic malaria are discussed. The human and parasite factors associated with differential clinical outcomes are described and the management and treatment strategies for the control of the disease are outlined. Further, the crucial gaps in the knowledge of asymptomatic malaria that should be the focus of future research towards development of more effective malaria control strategies are highlighted.</description>
        <link>http://www.malariajournal.com/content/11/1/29</link>
                <dc:creator>Dolie Laishram</dc:creator>
                <dc:creator>Patrick Sutton</dc:creator>
                <dc:creator>Nutan Nanda</dc:creator>
                <dc:creator>Vijay Sharma</dc:creator>
                <dc:creator>Ranbir Sobti</dc:creator>
                <dc:creator>Jane Carlton</dc:creator>
                <dc:creator>Hema Joshi</dc:creator>
                <dc:source>Malaria Journal 2012, null:29</dc:source>
        <dc:date>2012-01-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-11-29</dc:identifier>
                                    <dc:description>The pathogenesis of malaria is complex, and the clinical presentation of disease ranges from severe malaria, to mild and uncomplicated, to asymptomatic infections. Asymptomatic malaria remains a major challenge for malaria control programmes.</dc:description>
                <prism:require>/content/figures/1475-2875-11-29-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>29</prism:startingPage>
        <prism:publicationDate>2012-01-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/11/1/28">
        <title>Strengthening the policy setting process for global malaria control and elimination</title>
        <description>The scale-up of malaria control efforts in recent years, coupled with major investments in malaria research, has produced impressive public health impact in a number of countries and has led to the development of new tools and strategies aimed at further consolidating malaria control goals.  As a result, there is a growing need for the malaria policy setting process to rapidly review increasing amounts of evidence.The World Health Organization Global Malaria Programme, in keeping with its mandate to set evidence-informed policies for malaria control, has convened the Malaria Policy Advisory Committee as a mechanism to increase the timeliness, transparency, independence and relevance of its recommendations to World Health Organization member states in relation to malaria control and elimination.The Malaria Policy Advisory Committee, composed of 15 world-renowned malaria experts, will meet in full twice a year, with the inaugural meeting scheduled for 31 January to 2 February 2012 in Geneva.  Policy recommendations, and the evidence to support them, will be published within two months of every meeting as part of an open access Malaria Journal thematic series.  This article is a prelude to that series and provides the global malaria community with the background and overview of the Committee and its terms of reference.</description>
        <link>http://www.malariajournal.com/content/11/1/28</link>
                <dc:creator>Bianca D'Souza</dc:creator>
                <dc:creator>Robert Newman</dc:creator>
                <dc:source>Malaria Journal 2012, null:28</dc:source>
        <dc:date>2012-01-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-11-28</dc:identifier>
                                    <dc:description>A new Thematic Series in Malaria Journal will, after each meeting of the Malaria Policy Advisory Committee (MPAC), a new WHO committee, publish its recommendations and the evidence to support them.</dc:description>
                <prism:require>/content/figures/1475-2875-11-28-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>28</prism:startingPage>
        <prism:publicationDate>2012-01-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/11/1/27">
        <title>Visual and olfactory associative learning in the malaria vector Anopheles gambiae sensu stricto</title>
        <description>Background:
Memory and learning are critical aspects of the ecology of insect vectors of human pathogens because of their potential effects on contacts between vectors and their hosts. Despite this epidemiological importance, there have been only a limited number of studies investigating associative learning in insect vector species and none on Anopheline mosquitoes.
Methods:
A simple behavioural assays was developed to study visual and olfactory associative learning in Anopheles gambiae, the main vector of malaria in Africa. Two contrasted membrane qualities or levels of blood palatability were used as reinforcing stimuli for bi-directional conditioning during blood feeding.
Results:
Under such experimental conditions An. gambiae females learned very rapidly to associate visual (chequered and white patterns) and olfactory cues (presence and absence of cheese or Citronella smell) with the reinforcing stimuli (bloodmeal quality) and remembered the association for up to three days. Associative learning significantly increased with the strength of the conditioning stimuli used. Importantly, learning sometimes occurred faster when a positive reinforcing stimulus (palatable blood) was associated with an innately preferred cue (such as a darker visual pattern). However, the use of too attractive a cue (e.g. Shropshire cheese smell) was counter-productive and decreased learning success.
Conclusions:
The results address an important knowledge gap in mosquito ecology and emphasize the role of associative memory for An. gambiae&apos;s host finding and blood-feeding behaviour with important potential implications for vector control.</description>
        <link>http://www.malariajournal.com/content/11/1/27</link>
                <dc:creator>Nora Chilaka</dc:creator>
                <dc:creator>Elisabeth Perkins</dc:creator>
                <dc:creator>Frederic Tripet</dc:creator>
                <dc:source>Malaria Journal 2012, null:27</dc:source>
        <dc:date>2012-01-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-11-27</dc:identifier>
                                    <dc:description>The paper investigated associative learning in Anopheles
gambiae in a laboratory bioassay using visual and olfactory cues. The results address an important knowledge gap in mosquito ecology and emphasize the role of associative memory for host finding and blood-feeding behaviour, with important potential implications for vector control.</dc:description>
                <prism:require>/content/figures/1475-2875-11-27-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>27</prism:startingPage>
        <prism:publicationDate>2012-01-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/11/1/26">
        <title>Hyponatraemia in imported malaria: the pathophysiological role of vasopressin</title>
        <description>Background:
In the pathophysiology of hyponatraemia in malaria, the relative contribution of appropriate and inappropriate arginine vasopressin (AVP) release is unknown; the trigger for inappropriate AVP release is also unknown.
Methods:
Serum copeptin, a stable and sensitive marker for AVP release, was analysed in a large cohort of patients with imported malaria (204 patients) and in a small prospective substudy (23 patients) in which urine sodium and osmolality were also available. Hyponatraemia was classified as mild (serum sodium 131-134 mmol/l) and moderate-to-severe (&lt; 131 mmol/l).
Results:
Serum copeptin on admission was higher in patients with moderate-to-severe hyponatraemia (median 18.5 pmol/L) compared with normonatraemic patients (12.7 pmol/L, p&lt;0.05). Despite prompt fluid resuscitation, the time to normalization of serum sodium was longer in patients with moderate-to-severe hyponatraemia (median 2.9 days) than in patients with mild hyponatraemia (median 1.7 days, p&lt;0.001). A poor correlation was found between serum sodium and copeptin levels on admission (rs=-0.17, p=0.017). Stronger correlations were identified between serum C-reactive protein and copeptin (rs=-0.36, p&lt;0.0001) and between serum C-reactive protein and sodium (rs=0.33, p&lt;0.0001).  Data from the sub-study suggested inappropriate AVP release in seven of 13 hyponatraemic malaria patients; these patients had significantly higher body temperatures on admission.
Conclusions:
In hyponatraemic patients with imported malaria, AVP release was uniformly increased and was either appropriate or inappropriate. Although the exact trigger for inappropriate AVP release remains unknown, the higher body temperatures, correlations with C-reactive protein and long normalization times of serum sodium, suggest an important role of the host inflammatory response to the invading malaria parasite.</description>
        <link>http://www.malariajournal.com/content/11/1/26</link>
                <dc:creator>Ewout Hoorn</dc:creator>
                <dc:creator>Marlies van Wolfswinkel</dc:creator>
                <dc:creator>Dennis Hesselink</dc:creator>
                <dc:creator>Yolanda de Rijke</dc:creator>
                <dc:creator>Rob Koelewijn</dc:creator>
                <dc:creator>Jaap van Hellemond</dc:creator>
                <dc:creator>Perry van Genderen</dc:creator>
                <dc:source>Malaria Journal 2012, null:26</dc:source>
        <dc:date>2012-01-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-11-26</dc:identifier>
                                    <dc:description>This is a retrospective study of 519 cases of imported malaria, examining patterns and mechanisms of associated hyponatraemia. The results, which builds on work by the same authors published last year, is timely, because the issue of fluid resuscitation of patients with malaria controversial.</dc:description>
                <prism:require>/content/figures/1475-2875-11-26-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>26</prism:startingPage>
        <prism:publicationDate>2012-01-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/11/1/25">
        <title>Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa</title>
        <description>Background:
Artesunate-amodiaquine (AS&amp;AQ) is a widely used artemisinin combination therapy (ACT) for falciparum malaria. A comprehensive appreciation of its effects on haematology vs other anti-malarials is needed in view of potential safety liabilities.
Methods:
Individual-patient data analysis conducted on a database from seven randomized controlled trials conducted in sub-Saharan African comparing AS&amp;AQ to reference treatments in uncomplicated falciparum malaria patients of all ages. Haematologic values (white cells total and neutrophil counts, haemoglobin/haematocrit, platelets) were analysed as both continuous and categorical variables for their occurrence, (severity grade 1-4) and changes during follow-up. Risks and trends were calculated using multivariate logistic random effect models.
Results:
4,502 patients (72% &lt;5 years old), from 13 sites in nine countries with 28-day follow-up were treated with AS&amp;AQ (45%) or a comparator (other forms of ACT accounted for 27%, other combination 12%, mono-therapies 16%). Pre-treatment leucopaenia (3%) and neutropaenia (6%) were infrequent; anaemia was common (39%) as well as thrombocytopaenia (32%). The treatment-emergent adverse events incidence (TEAE = condition not present or less severe pre-treatment) was 11% for neutropaenia, 6% for thrombocytopaenia with AS&amp;AQ and not different from treatment groups; anaemia was higher with AS&amp;AQ (20%) or other forms of ACT (22%) than in non-artemisinin groups (4%, p = 0.001). Multivariate analysis showed that the risk of anaemia, thrombocytopaenia, and leucopaenia decreased with follow-up time, while neutropaenia increased; the risk of anaemia and thrombocytopaenia increased with higher baseline parasitaemia and parasitological reappearance. White cells total count was not a good surrogate for neutropaenia. No systematic significant difference between treatments was detected. Older patients were at lower risks.
Conclusion:
The effects of AS&amp;AQ on haematologic parameters were not different from those of other anti-malarial treatments used in sub-Saharan Africa. This analysis provides the basis for a broader evaluation of haematology following anti-malarial treatment. Continuing monitoring of haematologic safety on larger databases is required.</description>
        <link>http://www.malariajournal.com/content/11/1/25</link>
                <dc:creator>Julien Zwang</dc:creator>
                <dc:creator>Jean-Louis Ndiaye</dc:creator>
                <dc:creator>Abdoulaye Djimde</dc:creator>
                <dc:creator>Grant Dorsey</dc:creator>
                <dc:creator>Andreas Martensson</dc:creator>
                <dc:creator>Corine Karema</dc:creator>
                <dc:creator>Piero Olliaro</dc:creator>
                <dc:source>Malaria Journal 2012, null:25</dc:source>
        <dc:date>2012-01-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-11-25</dc:identifier>
                                    <dc:description>Effect of different antimalarial treatments on haematologic parameters comparing artesunate-amodiaquine against various single treatment lines and combination therapies.</dc:description>
                <prism:require>/content/figures/1475-2875-11-25-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>25</prism:startingPage>
        <prism:publicationDate>2012-01-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.malariajournal.com/content/11/1/24">
        <title>Aging partially restores the efficacy of malaria vector control in insecticide-resistant populations of Anopheles gambiae s.l. from Burkina Faso</title>
        <description>Background:
The operational impact of insecticide resistance on the effectiveness of long-lasting insecticide nets (LLINs) and indoor residual spraying (IRS) is poorly understood. One factor which may prolong the effectiveness of these tools in the field is the increase in insecticide susceptibility with mosquito age. In this study, LLINs and IRS were tested against young (three to five days) and old (17-19 days) pyrethroid resistant Anopheles gambiae s.l. from Burkina Faso.
Methods:
Blood-fed adult Anopheles gambiae s.l. were collected from south-west Burkina Faso and identified to species/form level. Cohorts of the F1 progeny of An. gambiae s.s. S-forms were exposed to deltamethrin (0.05%) at three to five or 17-19 days post-emergence and tested for the frequency of the resistance allele 1014F. Isofemale lines of the M, S- form of An. gambiae s.s. and Anopheles arabiensis were exposed in WHO cone tests to either a) LLINs deployed in households for two years or (b) bendiocarb sprayed walls.
Results:
Mortality rates in response to deltamethrin (0.05%) increased from levels indicative of strong resistance in three to five day old F1 mosquitoes, to near full susceptibility in the 17-19 day old cohort. On exposure to LLINs sampled from the field, the mortality rate in isofemale lines was higher in older mosquitoes than young (OR = 5.28, CI 95% = 2.81-9.92), although the mortality estimates were affected by the LLIN tested. In general, the LLINs sampled from the field performed poorly in WHO cone bioassays using either laboratory susceptible or field caught mosquito populations. Finally, there was a clear relationship between mortality and age on exposure to bendiocarb-sprayed walls, with older mosquitoes again proving more susceptible (OR = 3.39, CI 95% = 2.35-4.90).
Conclusions:
Age is a key factor determining the susceptibility of mosquitoes to insecticides, not only in laboratory studies, but in response to field-based vector control interventions. This has important implications for understanding the epidemiological impact of resistance. If mosquitoes old enough to transmit malaria are still being suppressed with available insecticides, is resistance potentially having less of an impact than often assumed? However, the poor performance of LLINs used in this study in Burkina Faso, is a cause for concern and requires urgent investigation.</description>
        <link>http://www.malariajournal.com/content/11/1/24</link>
                <dc:creator>Christopher Jones</dc:creator>
                <dc:creator>Antoine Sanou</dc:creator>
                <dc:creator>Wamdaogo Guelbeogo</dc:creator>
                <dc:creator>N'Fale Sagnon</dc:creator>
                <dc:creator>Paul Johnson</dc:creator>
                <dc:creator>Hilary Ranson</dc:creator>
                <dc:source>Malaria Journal 2012, null:24</dc:source>
        <dc:date>2012-01-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2875-11-24</dc:identifier>
                                    <dc:description>The main finding here is that older mosquitoes are more susceptible to insecticides. This has important implications for understanding the epidemiological impact of resistance in field-based vector control interventions.</dc:description>
                <prism:require>/content/figures/1475-2875-11-24-toc.gif</prism:require>
                <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:issn>1475-2875</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>24</prism:startingPage>
        <prism:publicationDate>2012-01-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

